UPEXI INC (UPXI)

US39959A1060 - Common Stock

3.71  +0.2 (+5.7%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to UPXI. UPXI was compared to 36 industry peers in the Personal Care Products industry. UPXI may be in some trouble as it scores bad on both profitability and health. UPXI is valied quite expensively at the moment, while it does show a decent growth rate.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year UPXI has reported negative net income.
UPXI had a negative operating cash flow in the past year.
In the past 5 years UPXI reported 4 times negative net income.
In multiple years UPXI reported negative operating cash flow during the last 5 years.

1.2 Ratios

UPXI has a worse Return On Assets (-43.59%) than 82.86% of its industry peers.
The Return On Equity of UPXI (-111.66%) is worse than 80.00% of its industry peers.
Industry RankSector Rank
ROA -43.59%
ROE -111.66%
ROIC N/A
ROA(3y)-6.7%
ROA(5y)-22.4%
ROE(3y)-17.75%
ROE(5y)-480.96%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

UPXI has a worse Gross Margin (31.53%) than 80.00% of its industry peers.
UPXI's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for UPXI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.25%
GM growth 5YN/A

More info and screens

0

2. Health

2.1 Basic Checks

UPXI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for UPXI has been increased compared to 1 year ago.
Compared to 1 year ago, UPXI has a worse debt to assets ratio.

2.2 Solvency

UPXI has an Altman-Z score of 0.46. This is a bad value and indicates that UPXI is not financially healthy and even has some risk of bankruptcy.
UPXI has a Altman-Z score of 0.46. This is in the lower half of the industry: UPXI underperforms 77.14% of its industry peers.
A Debt/Equity ratio of 0.60 indicates that UPXI is somewhat dependend on debt financing.
UPXI's Debt to Equity ratio of 0.60 is on the low side compared to the rest of the industry. UPXI is outperformed by 68.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF N/A
Altman-Z 0.46
ROIC/WACCN/A
WACC9.89%

2.3 Liquidity

UPXI has a Current Ratio of 0.70. This is a bad value and indicates that UPXI is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.70, UPXI is not doing good in the industry: 94.29% of the companies in the same industry are doing better.
UPXI has a Quick Ratio of 0.70. This is a bad value and indicates that UPXI is not financially healthy enough and could expect problems in meeting its short term obligations.
UPXI's Quick ratio of 0.33 is on the low side compared to the rest of the industry. UPXI is outperformed by 94.29% of its industry peers.
Industry RankSector Rank
Current Ratio 0.7
Quick Ratio 0.33

More info and screens

4

3. Growth

3.1 Past

The earnings per share for UPXI have decreased strongly by -426.36% in the last year.
UPXI shows a strong growth in Revenue. In the last year, the Revenue has grown by 44.18%.
The Revenue has been growing by 121.64% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-426.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-79.74%
Revenue 1Y (TTM)44.18%
Revenue growth 3Y121.64%
Revenue growth 5YN/A
Sales Q2Q%-40.36%

3.2 Future

UPXI is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -30.38% yearly.
UPXI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.17% yearly.
EPS Next Y-145%
EPS Next 2Y-30.38%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.26%
Revenue Next 2Y7.17%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

UPXI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year UPXI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A cheap valuation may be justified as UPXI's earnings are expected to decrease with -30.38% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-30.38%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

UPXI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

UPEXI INC

NASDAQ:UPXI (1/2/2025, 1:19:46 PM)

3.71

+0.2 (+5.7%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)09-11 2024-09-11/amc
Earnings (Next)N/A N/A
Inst Owners3.2%
Inst Owner ChangeN/A
Ins Owners27.48%
Ins Owner Change0%
Market Cap3.86M
Analysts43.33
Price Target25.5 (587.33%)
Short Float %2.75%
Short Ratio0.02
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-96.08%
Min EPS beat(2)-96.08%
Max EPS beat(2)-96.08%
EPS beat(4)1
Avg EPS beat(4)-134.75%
Min EPS beat(4)-370.59%
Max EPS beat(4)23.75%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-32.15%
Min Revenue beat(2)-35.64%
Max Revenue beat(2)-28.67%
Revenue beat(4)0
Avg Revenue beat(4)-24.53%
Min Revenue beat(4)-35.64%
Max Revenue beat(4)-1.79%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)1900%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1900%
EPS NY rev (1m)0%
EPS NY rev (3m)-1900%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.04
P/FCF N/A
P/OCF N/A
P/B 0.17
P/tB 2.22
EV/EBITDA N/A
EPS(TTM)-17
EYN/A
EPS(NY)-6.94
Fwd EYN/A
FCF(TTM)-7.55
FCFYN/A
OCF(TTM)-6.11
OCFYN/A
SpS100.72
BVpS21.21
TBVpS1.67
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -43.59%
ROE -111.66%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 31.53%
FCFM N/A
ROA(3y)-6.7%
ROA(5y)-22.4%
ROE(3y)-17.75%
ROE(5y)-480.96%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.25%
GM growth 5YN/A
F-Score3
Asset Turnover1.85
Health
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 29.78%
Cap/Sales 1.43%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.7
Quick Ratio 0.33
Altman-Z 0.46
F-Score3
WACC9.89%
ROIC/WACCN/A
Cap/Depr(3y)118.58%
Cap/Depr(5y)197.29%
Cap/Sales(3y)10.23%
Cap/Sales(5y)13.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-426.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-79.74%
EPS Next Y-145%
EPS Next 2Y-30.38%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)44.18%
Revenue growth 3Y121.64%
Revenue growth 5YN/A
Sales Q2Q%-40.36%
Revenue Next Year6.26%
Revenue Next 2Y7.17%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year121.71%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-302.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-226.83%
OCF growth 3YN/A
OCF growth 5YN/A